Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway

Oncology Reports

Volumn 34, Issue 4, 2015, Pages 1787-1794

  Fan, Qiong ^a   Qiu, Mei Ting ^a   Zhu, Zhu ^b   Zhou, Jin Hua ^c   Chen, Limo ^b   Zhou, Ye ^a   Gu, Wei ^a   Wang, Li Hua ^a   Li, Zhu Nan ^a   Xu, Ying ^a   Cheng, Wei Wei ^a   Wu, Dan ^a   Bao, Wei ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cervical cancer; Epithelial mesenchymal transition; Metastasis; Prognosis; Transforming growth factor ; Twist

Indexed keywords

SMAD3 PROTEIN; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; UPREGULATION; UTERINE CERVIX CANCER; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TWIST TRANSCRIPTION FACTOR; UTERINE CERVICAL NEOPLASMS;

EID: 84939164679     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4143     Document Type: Article

References (39)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386, 2015.
3. Alemany L, de Sanjosé S, Tous S, Quint W, Vallejos C, Shin HR, Bravo LE, Alonso P, Lima MA, Guimerà N, et al; RIS HPV TT Study Group: Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer 135: 88-95, 2014.
4. Chang L, Ci P, Shi J, Zhai K, Feng X, Colombara D, Wang W, Qiao Y, Chen W and Wu Y: Distribution of genital wart human papillomavirus genotypes in China: A multi-center study. J Med Virol 85: 1765-1774, 2013.
5. Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li SQ, Zhao Y, Chang H, Xue QP and Yang CX: Knowledge of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccine and its correlates among medical students in Southwest China: A multi-center cross-sectional survey. Asian Pac J Cancer Prev 15: 5773-5779, 2014.
6. Kang Y and Massagué J: Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118: 277-279, 2004.
7. Christiansen JJ and Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326, 2006.
8. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
9. Bao W, Qiu H, Yang T, Luo X, Zhang H and Wan X: Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One 8: e70616, 2013.
10. Castanon I and Baylies MK: A Twist in fate: Evolutionary comparison of Twist structure and function. Gene 287: 11-22, 2002.
11. Chen ZF and Behringer RR: Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9: 686-699, 1995.
12. E l Ghouzzi V, Legeai-Mallet L, Aresta S, Benoist C, Munnich A, de Gunzburg J and Bonaventure J: Saethre-Chotzen mutations cause Twist protein degradation or impaired nuclear location. Hum Mol Genet 9: 813-819, 2000.
13. Yousfi M, Lasmoles F, El Ghouzzi V and Marie PJ: Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNFalpha expression and caspase-2 activation. Hum Mol Genet 11: 359-369, 2002.
14. Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak A P, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, et al: Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65: 10801-10809, 2005.
15. Wallerand H, Robert G, Pasticier G, Ravaud A, Ballanger P, Reiter RE and Ferrière JM: The epithelial-mesenchymal transition-inducing factor Twist is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol 28: 473-479, 2010.
16. Zhu DY, Guo QS, Li YL, Cui B, Guo J, Liu JX and Li P: Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. World J Gastroenterol 20: 18306-18315, 2014.
17. Zhu K, Chen L, Han X, Wang J and Wang J: Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. Oncol Rep 27: 1027-1034, 2012.
18. Tirumani SH, Shanbhogue AK and Prasad SR: Current concepts in the diagnosis and management of endometrial and cervical carcinomas. Radiol Clin North Am 51: 1087-1110, 2013.
19. Bao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-MIR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 12: 155, 2013.
20. Shibata K, Kajiyama H, Ino K, Terauchi M, Yamamoto E, Nawa A, Nomura S and Kikkawa F: Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 19: 81-85, 2008.
21. Hou CH, Lin FL, Hou SM and Liu JF: Cyr61 promotes epithelialmesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol Cancer 13: 236, 2014.
22. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
23. Choo KB, Huang CJ, Chen CM, Han CP and Au LC: Jun-B oncogene aberrations in cervical cancer cell lines. Cancer Lett 93: 249-253, 1995.
24. N dubisi B, Sanz S, Lu L, Podczaski E, Benrubi G and Masood S: The prognostic value of HER-2/neu oncogene in cervical cancer. Ann Clin Lab Sci 27: 396-401, 1997.
25. Mehdi SJ, Alam MS, Batra S and Rizvi MM: Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma. Med Oncol 28: 1520-1526, 2011.
26. Rizvi MM, Alam MS, Ali A, Mehdi SJ, Batra S and Mandal A K: Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 137: 1255-1262, 2011.
27. A lam MS, Ali A, Mehdi SJ, Alyasiri NS, Kazim Z, Batra S, Mandal AK and Rizvi MM: HPV typing and its relation with apoptosis in cervical carcinoma from Indian population. Tumour Biol 33: 17-22, 2012.
28. Rughooputh S, Manraj S, Eddoo R and Greenwell P: Expression of the c-myc oncogene and the presence of HPV 18: Possible surrogate markers for cervical cancer? Br J Biomed Sci 66: 74-78, 2009.
29. Lee MY, Chou CY, Tang MJ and Shen MR: Epithelialmesenchymal transition in cervical cancer: Correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14: 4743-4750, 2008.
30. Liu Y, Qian W, Zhang J, Dong Y, Shi C, Liu Z and Wu S: The indicative function of Twist2 and E-cadherin in HPV oncogeneinduced epithelial-mesenchymal transition of cervical cancer cells. Oncol Rep 33: 639-650, 2015.
31. Wang T, Li Y, Wang W, Tuerhanjiang A, Wu Z, Yang R, Yuan M, Ma D, Wang W and Wang S: Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence. Hum Pathol 45: 1839-1846, 2014.
32. Samatov TR, Tonevitsky AG and Schumacher U: Epithelialmesenchymal transition: Focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer 12: 107, 2013.
33. Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15: 178-196, 2014.
34. Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, et al: Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 124: 112-118, 2012.
35. Qureshi R, Arora H and Rizvi MA: EMT in cervical cancer: Its role in tumour progression and response to therapy. Cancer Lett 356 (2 Pt B): 321-331, 2015.
36. Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L and Ouyang G: Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30: 4707-4720, 2011.
37. Lamouille S and Derynck R: Cell size and invasion in TGF-betainduced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178: 437-451, 2007.
38. Comerci JT Jr, Runowicz CD, Flanders KC, De Victoria C, Fields AL, Kadish AS and Goldberg GL: Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 77: 1107-1114, 1996.
39. Kloth JN, Fleuren GJ, Oosting J, de Menezes RX, Eilers PH, Kenter GG and Gorter A: Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines. Carcinogenesis 26: 1493-1502, 2005.